GET THE APP

Polycystic Ovary Syndrome | 59674
Gynecology & Obstetrics

Gynecology & Obstetrics
Open Access

ISSN: 2161-0932

Polycystic Ovary Syndrome


6th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics

August 09, 2021 | Webinar

Khodavirdilou Lida

Tabriz university of medical science, faculty of pharmacy, Iran

Posters & Accepted Abstracts: Gynecol Obstet (Sunnyvale)

Abstract :

Background: Cervical dilation is indicated prior to performing various gynecological procedures. However, gynecologists are at times confronted with a stenotic or tight cervix, resistant to dilation. This can be problematic particularly when cervical ripening has not been attempted hours before the start of the procedure. Objective: This study aims to investigate the efficacy of the administration of hyoscine butylbromide for cervical dilation for immediate dilation of the tight or stenotic cervix. Materials and Methods: In this clinical trial study, a population of 40 women, aged 20-70 yr with a stenotic cervix, evidenced by resistance to pass dilator #2 through their cervical canal were compared. Cervical patency was assessed 10 min following intra-cervical canal instillation of hyoscine butylbromide. Results: Cervical width of 57.5% of patients became wider, as evidenced by the passage of the number 4 Hegar dilator through the cervical canal without resistance. Independent T-tests did not reveal any statistically significant difference between the two groups based on their age. Fisher Exact test revealed a statistically significant difference between the two groups based on the prior route of delivery, with a more statistically significant response in patients who had vaginal deliveries. Conclusion: Intra-cervical canal instillation of hyoscine butylbromide is effective in immediate dilation of the tight or stenotic cervix during intra-uterine procedures.

Top